»ó´Ü¿©¹é
±â»ç (Àüü 2,099°Ç)
[Cover Story] ÁöÁúÄ¡·á 'PCSK9 ±â¹Ý¿ä¹ý'À¸·Î È®Àå ÀÌ»óµ· ±âÀÚ 2016-12-05 10:17
[Late Breaking Studies] AHA¡¤ASA, Ç÷°ü¼º ÀÎÁöÀå¾Ö ¿¹¹æ¡¤Ä¡·áÀü·« Á¦½Ã ÀÌ»óµ· ±âÀÚ 2016-12-04 22:18
[Drug Review] ±º¿õÇÒ°Å DPP-4 ¾ïÁ¦Á¦, ÀÓ»óÀǵéÀÇ ¼±ÅÃÀº? ÀÓ¼¼Çü ±âÀÚ 2016-12-04 22:14
[Conference Report] APHRS 2016 ÀÓ¼¼Çü ±âÀÚ 2016-12-04 21:47
[Conference Report] AHA 2016 ÀÓ¼¼Çü ±âÀÚ 2016-12-04 17:50
¶óÀÎ
[Conference Report] WSC 2016 ÀÓ¼¼Çü ±âÀÚ 2016-12-04 17:39
[Deep in Guideline] ESC 2016³â ½É¹æ¼¼µ¿ °¡À̵å¶óÀÎ ÀÓ¼¼Çü ±âÀÚ 2016-12-04 17:16
[Conference Report] icdm 2016 ÇÏÀ̶óÀÌÆ® ÀÌ»óµ· ±âÀÚ 2016-11-15 10:48
[Conference Report] EASD 2016 ÇÏÀ̶óÀÌÆ® ÀÓ¼¼Çü ±âÀÚ 2016-11-15 10:18
[Sub Story] Çѱ¹ÀÎ ´ç´¢º´ À¯º´·ü ¡®14%¡¯ ¿ª´ë ÃÖ°íÄ¡ ÀÌ»óµ· ±âÀÚ 2016-11-14 20:02
¶óÀÎ
[Sub Story] ¸ÞÆ®Æ÷¸£¹Î Àå±â°üÂû °á°ú, ´ç´¢º´ ¿¹¹æÈ¿°ú Áö¼Ó ÀÌ»óµ· ±âÀÚ 2016-11-14 19:59
[Sub Story] ÇÇ¿À±Û¸®Å¸Á¸¡¤¾ÆÄ«º¸½º ´ç´¢º´ ¿¹¹æ ÀÔÁõ ÀÌ»óµ· ±âÀÚ 2016-11-14 19:55
[Drug Review] Á÷µà¿À XR, Çѱ¹ÀΠȯÀÚ ¡®¸ÂÃãÀü·«¡¯ ³ë¸°´Ù ÀÓ¼¼Çü ±âÀÚ 2016-11-14 19:51
[Sub Story] °¡À̵å¶óÀÎÀÌ ¸»ÇÏ´Â ´ç´¢º´ ¿¹¹æ ¾à¹°Ä¡·á ÀÌ»óµ· ±âÀÚ 2016-11-14 19:48
[Sub Story] Ç÷´çÁ¶Àý = Ç÷°üÇÕº´Áõ ¿¹¹æ ÀÌ»óµ· ±âÀÚ 2016-11-14 19:45
¶óÀÎ
[Sub Story] ¸ÞÆ®Æ÷¸£¹ÎÀÇ ½ÉÇ÷°üÇÕº´Áõ °³¼±È¿°ú ÀÌ»óµ· ±âÀÚ 2016-11-14 19:42
[Sub Story] ÇÇ¿À±Û¸®Å¸Á¸, PROactive¿¡¼­ IRIS±îÁö ÀÌ»óµ· ±âÀÚ 2016-11-14 19:39
[Sub Story] GLP-1 ¼ö¿ëü ÀÛ¿ëÁ¦ ¿¬ÀÌÀº ³¶º¸ ¡°½ÉÇ÷°üÁúȯ ¿¹¹æ¡± ÀÌ»óµ· ±âÀÚ 2016-11-14 19:35
[Sub Story] SGLT-2 ¾ïÁ¦Á¦ ½ÉÇ÷°üÁúȯ ¿¹¹æ °ø½ÄÈ­ ÀÌ»óµ· ±âÀÚ 2016-11-14 19:32
[Late Breaking Studies] ±Û¸®Å¬¶óÁöµå°¡ ÇÏ¸é ¼³Æù¿ä¼ÒÁ¦µµ ´Þ¶óÁø´Ù ÀÌ»óµ· ±âÀÚ 2016-11-14 18:44
Back to Top